Jemperli® (dostarlimab-gxly)
for Endometrial Cancer
Jemperli (dostarlimab-gxly) is an immunotherapy used to treat certain types of endometrial cancer and solid tumors. As a PD-1–blocking antibody, it reactivates T-cells by preventing the PD-1 protein from inactivating them, enabling the immune system to detect and destroy cancer cells.
